- Cannabis Sector Faces Policy Headwinds - Jan 21Federal and political developments put cannabis stocks under pressure today as hemp THC protections were removed from a spending bill. State-level advances offer pockets of support, but risks dominate the near term.
- Cannabis Legal Risk in Florida - Jan 21Florida law enforcement arrested workers tied to an MSO-funded adult-use legalization campaign, raising legal and political uncertainty for the cannabis sector. Investors should watch campaign filings, MSO disclosures, and market reaction.
- Cannabis Sector Faces Regulatory Headwinds - Jan 20Regulatory proposals in New Jersey and Florida, a missed federal research deadline, and Michigan's revenue slip set a cautious tone for cannabis investors. Read what to watch next and how you might position your portfolio.
- Cannabis Market: Sales, Law Changes - Jan 20State-level shifts set a mixed tone for cannabis investors on Jan 20. Michigan logged a volume record but revenue fell, while Missouri and Indiana pursue divergent regulatory changes.
- Cannabis Policy Uncertainty Persists - Jan 19Federal hemp debate, Missouri patient guidance and an Indiana setback left the cannabis sector facing regulatory uncertainty while markets were closed for the holiday. Read what this means for growers, patients and investors ahead of Tuesday.
- Cannabis Sector: Regulation and Sales Trends - Jan 19Montana's adult-use market topped $1 billion in sales since 2022 while Michigan lawmakers push for a statewide reference lab and Indiana tightens hemp THC rules. Read what investors should watch heading into the long weekend.
- Cannabis Regulation Push in Michigan - Jan 18Michigan lawmakers introduced a bill to create a statewide cannabis reference lab, aiming to standardize testing and boost consumer safety. The move could improve market confidence but raises compliance costs for labs and producers.
- Cannabis Faces Hemp THC Rules - Jan 17Indiana approved a bill to restrict intoxicating and synthetic hemp THC products, aligning state law with a federal ban. The move raises compliance and market access questions for hemp product makers and retailers.
- Cannabis Sector: Policy Noise & Local Moves - Jan 16Mixed regulatory signals dominated the cannabis sector on Jan 16: lawmakers pushed to delay a federal hemp THC ban even as state-level pushback and retail closures underscore persistent political and operational risks. Investors should track ballot access, federal rulemaking, and state legislative calendars.
- Cannabis Sector: State Wins & Sales Lift - Jan 15State-level momentum and record demand headline the cannabis sector this morning. Montana posted record adult-use sales and lawmakers in Virginia and Georgia advanced measures that could expand markets—offset by a federal rider blocking D.C. sales.
- Cannabis Sector Sees M&A Momentum - Jan 14A wave of deal activity tied to federal rescheduling, plus a New Jersey interstate-commerce bill and state-level psychedelic action, shifted investor focus from soft state sales to growth catalysts. Expect M&A, regulatory milestones and busy state legislatures to drive near-term moves.
- Cannabis Sector Mixed Signals on Policy - Jan 13A coordinated pushback warning rattled the cannabis narrative today, but policy wins and federal data offset some concern. New Jersey approved a funded psilocybin pilot and federal survey findings ease youth-use fears.
- Cannabis Sector Sees Growth Signals - Jan 12Texas medical cannabis expansion and Ohio topping $1.09B in first full adult-use year drove the day’s headlines, offset by regulatory questions over hemp-derived THC and a Maine repeal petition. Investors should watch Texas rulemaking, Maine ballot activity and next-state sales updates.
- Cannabis Sector Eyes DOJ Rescheduling Move - Jan 12Federal momentum returned Monday as a GOP lawmaker said the DOJ won’t delay cannabis rescheduling, while state-level actions in Florida, Kentucky and Massachusetts add near-term catalysts. Investors should watch policy timing and MSO exposure today.
- Cannabis Sector: Pre-Rolls Growth vs. Regulation - Jan 11Retail momentum from pre-rolls is getting fresh attention as a tangible sales driver, while state-level regulatory fights in Wisconsin underscore continuing policy risk. Investors should weigh near-term retail upside against patchwork hemp THC rules.
- Cannabis: Sales Milestone, Banking Headwinds - Jan 9Massachusetts reached $10B in lifetime cannabis sales and posted a record $1.65B in 2025, but big banks still shun the industry despite federal rescheduling. Operators face pricing pressure, compliance costs and watch for state-level rollout progress.
- Cannabis Sector Gains on Federal Protections - Jan 9Congress approved federal medical cannabis protections today, a major policy shift that could expand markets and ease banking and research. Celebrity-brand fraud claims add a legal reminder for investors to watch licensing and reputational risk.
- Cannabis Sector Gains Momentum - Jan 8Tilray reported record Q2 revenue and moved to net cash while the U.S. House cleared a path for federal rescheduling, lifting sector sentiment. State-level price pressure and a Massachusetts ballot review keep risks in view.
- Cannabis Policy Momentum and Supply Woes - Jan 7State-level legalization momentum met operational hiccups today as Kentucky supply shortfalls contrasted with New Hampshire and Hawaii reform moves and a federal plea for full legalization. Investors should watch state ballots, supply logistics and federal guidance next.
- Cannabis Policy Shifts Drive Risk for Investors - Jan 6A flurry of state and federal policy moves on Jan 6 shifted the narrative for cannabis investors: Florida proposals threaten patient registrations, the Senate confirmed an ONDCP director, and Indiana filed a low‑level legalization bill. These developments tighten regulatory risk in key markets while offering potential upside if rescheduling momentum continues.
- Cannabis Sector Updates: Wyld's Acquisition & Sales Trends - Jan 6Today's cannabis sector highlights include Wyld's acquisition of Grön and slow sales growth in December. Investors should monitor regulatory developments and market trends.